Federal Register / Vol. 75, No. 104 / Tuesday, June 1, 2010 / Notices 30409 

Biomedical Research and Research Training 

Review Subcommittee B. 

Date: June 18, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Arthur L. Zachary, PhD, 

Scientific Review Officer, Office of Scientific 

Review, National Institute of General Medical 

Sciences, National Institutes of Health, 

Natcher Building, Room 3AN–18, Bethesda, 

MD 20892, (301) 594–2886, 

zacharya@nigms.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.375, Minority Biomedical 

Research Support; 93.821, Cell Biology and 

Biophysics Research; 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.862, Genetics and 

Developmental Biology Research; 93.88, 

Minority Access to Research Careers; 93.96, 

Special Minority Initiatives, National 

Institutes of Health, HHS) 

Dated: May 25, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–13040 Filed 5–28–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Interest Projects (SIPs): Workplace 

Health Research Network (WHRN)— 

Coordinating Center, SIP 10–031 and 

WHRN—Collaborating Centers, SIP 10– 

032, Initial Review 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time and Date: 11 a.m.–5 p.m., June 29, 

2010 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c) (4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters to be Discussed: The meeting will 

include the initial review, discussion, and 

evaluation of applications received in 

response to ‘‘Workplace Health Research 

Network (WHRN)—Coordinating Center, SIP 

10–031 and WHRN—Collaborating Centers, 

SIP 10–032, initial review.’’ 

Contact Person for More Information: 

Michelle Mathieson, Public Health Analyst, 

National Center for Chronic Disease and 

Health Promotion, Office of the Director, 

Extramural Research Program Office, CDC, 

4770 Buford Highway, NE., Mailstop K–92, 

Atlanta, GA 30341, Telephone: (770) 488– 

3068, E-mail: mth8@cdc.gov. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: May 21, 2010. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2010–13101 Filed 6–01–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable materials, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Initial 

Review Group, Neurological Sciences and 

Disorders K. 

Date: June 21, 2010. 

Time: 8 a.m. to 6:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Shanta Rajaram, PhD, 

Scientific Review Officer, Scientific Review 

Branch, NINDS/NIH/DHHS, 6001 Executive 

Blvd., Suite 3208, MSC 9529, Bethesda, MD 

20852. 301–435–6033. 

Rajarams@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.853, Clinical Research 

Related to Neurological Disorders; 93.854, 

Biological Basis Research in the 

Neurosciences, National Institutes of Health, 

HHS) 

Dated: May 20, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–12780 Filed 5–28–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Committee to the Director 

(ACD), Centers for Disease Control and 

Prevention—Ethics Subcommittee (ES) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting of the 

aforementioned subcommittee: 

Time and Date: 1 p.m.–3:30 p.m., 

June 17, 2010. 

Place: Teleconference. To participate, 

please dial (866) 919–3560 and enter 

passcode 4168828 for access. 

Status: Open to the public, limited 

only by availability of telephone ports. 

The public is welcome to participate 

during the public comment periods. A 

public comment period is tentatively 

scheduled for 3 p.m.–3:15 p.m. 

Purpose: The ES will provide counsel 

to the ACD, CDC, regarding a broad 

range of public health ethics questions 

and issues arising from programs, 

scientists and practitioners. 

Matter to be Discussed: Agenda items 

will include the following topics: 

Development of a strategy to support 

state and local health departments in 

their efforts to address public health 

ethics issues and coordination of these 

efforts with the CDC Office of State, 

Tribal, Local, and Territorial Support; 

steps for addressing ACD input on the 

ventilator guidance document; 

development of public health ethics 

cases; future priorities for the ES; and 

updates on CDC’s public health ethics 

activities. 

The agenda is subject to change as 

priorities dictate. 

Contact Person for More Information: 

Drue Barrett, PhD, Designated Federal 

Officer, ACD, CDC–ES, 1600 Clifton 

Road, N.E., M/S D–50, Atlanta, GA 

30333. Telephone: (404) 639–4690. Email: dbarrett@cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both CDC 

and the Agency for Toxic Substances 

and Disease Registry. 


erowe on DSK5CLS3C1PROD with NOTICES